Champions Oncology Inc
NASDAQ:CSBR

Watchlist Manager
Champions Oncology Inc Logo
Champions Oncology Inc
NASDAQ:CSBR
Watchlist
Price: 4.7 USD -0.63% Market Closed
Updated: May 19, 2024

Champions Oncology Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Champions Oncology Inc
Income from Continuing Operations Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Champions Oncology Inc
NASDAQ:CSBR
Income from Continuing Operations
-$9.7m
CAGR 3-Years
-113%
CAGR 5-Years
-108%
CAGR 10-Years
-3%
Thermo Fisher Scientific Inc
NYSE:TMO
Income from Continuing Operations
$6B
CAGR 3-Years
-9%
CAGR 5-Years
13%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
Income from Continuing Operations
$7.5B
CAGR 3-Years
17%
CAGR 5-Years
28%
CAGR 10-Years
12%
Mettler-Toledo International Inc
NYSE:MTD
Income from Continuing Operations
$777.8m
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
10%
Agilent Technologies Inc
NYSE:A
Income from Continuing Operations
$1.2B
CAGR 3-Years
15%
CAGR 5-Years
1%
CAGR 10-Years
22%
IQVIA Holdings Inc
NYSE:IQV
Income from Continuing Operations
$1.4B
CAGR 3-Years
65%
CAGR 5-Years
42%
CAGR 10-Years
20%

See Also

What is Champions Oncology Inc's Income from Continuing Operations?
Income from Continuing Operations
-9.7m USD

Based on the financial report for Jan 31, 2024, Champions Oncology Inc's Income from Continuing Operations amounts to -9.7m USD.

What is Champions Oncology Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-3%

Over the last year, the Income from Continuing Operations growth was -212%. The average annual Income from Continuing Operations growth rates for Champions Oncology Inc have been -113% over the past three years , -108% over the past five years , and -3% over the past ten years .